Jesse I. Treu

Jesse I. Treu is the Board Member at Veracyte Inc.

Dr. Treu has been a Partner of Domain since its inception in 1985. He has been a director of more than 30 early-stage healthcare companies, 18 of which have so far become successful public companies.

At present, his board memberships include

Afferent Pharmaceuticals,

CoLucid Pharmaceuticals,

Regado Biosciences,

Tandem Diabetes Care and

Veracyte.

He has served as a Founder, President and Chairman of numerous venture stage companies.

Prior to the formation of Domain, Dr. Treu was vice president of the predecessor organization to The Wilkerson Group, and its venture capital arm, CW Ventures. While at CW Ventures, he served as President and CEO of Microsonics, a pioneer in computer image processing for cardiology.

Prior to that, Dr. Treu held executive positions at Technicon Instruments Corporation (now Siemens Medical Solutions Diagnostics), and at GE.

Education: B.S. - Rensselaer Polytechnic Institute, 1968 M.A. & Ph.D. - Princeton University, 1971, 1973

Jesse I. Treu is the Founding Partner at Domain Associates, based in New York, New York, United States, North America. With a background in Venture Capital, Jesse I. Treu has a rich history of leadership and innovation.Jesse I. Treu studied BS unknown at Rensselaer Polytechnic Institute. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.